O'Connor John James 4

What Happened
John O'Connor, a director of LEMAITRE VASCULAR (LMAT), received 476 shares of common stock on February 26, 2026 as the settlement of a Performance Share Unit (PSU) award. The shares were issued at $0.00 per share (no cash was paid). The Form 4 also reports two small derivative conversions/exercises (code M): one acquisition of 1 share and one disposition of 1 share, each at $0.00; footnotes link these to dividend-equivalent rights released in connection with the PSU vesting.

Key Details

• Transaction date: February 26, 2026 (Form 4 filed March 2, 2026 — timely filing).
• Award settlement: 476 shares acquired at $0.00 (total cash paid = $0).
• Derivative actions: one 1-share acquisition and one 1-share disposition (both $0.00) reported as exercises/conversions (code M).
• Shares owned after transaction: not specified in the provided filing extract.
• Footnotes:
  • F1: 476 shares were issued upon settlement of a PSU granted Dec 6, 2024; 1/3 vested upon satisfaction of the performance condition on 2/26/2026, with the remaining shares vesting in equal annual installments over the next two years.
  • F2/F3: The 1-share entries relate to release of dividend-equivalent rights (one-for-one) tied to the PSU; each dividend equivalent is the economic equivalent of one common share.
• No sale proceeds or cash purchase involved — this was an award settlement/vesting event, not an open-market buy or sale.

Context

• This is a standard equity award vesting/settlement disclosure. Such award settlements typically reflect compensation realization rather than a buy or sell decision by the insider.
• The PSU award still has remaining unvested portions that will vest on future anniversaries if applicable performance/time conditions are met.